AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.03
-0.08 (-1.57%)
At close: Feb 27, 2026, 4:00 PM EST
5.07
+0.04 (0.80%)
After-hours: Feb 27, 2026, 4:17 PM EST
AVITA Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AVITA Medical stock have an average target of 7.17, with a low estimate of 3.50 and a high estimate of 10. The average target predicts an increase of 42.54% from the current stock price of 5.03.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AVITA Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +98.81% | Feb 17, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +98.81% | Jan 26, 2026 |
| Lake Street | Lake Street | Hold Maintains $3 → $3.5 | Hold | Maintains | $3 → $3.5 | -30.42% | Jan 16, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 → $10 | Strong Buy | Maintains | $14 → $10 | +98.81% | Jan 15, 2026 |
| BTIG | BTIG | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2025 |
Financial Forecast
Revenue This Year
87.14M
from 71.61M
Increased by 21.69%
Revenue Next Year
130.35M
from 87.14M
Increased by 49.58%
EPS This Year
-0.88
from -1.74
EPS Next Year
-0.33
from -0.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 105.3M | 263.6M | |||
| Avg | 87.1M | 130.4M | |||
| Low | 78.4M | 88.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 47.1% | 202.5% | |||
| Avg | 21.7% | 49.6% | |||
| Low | 9.5% | 1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.18 | -0.03 | |||
| Avg | -0.88 | -0.33 | |||
| Low | -1.50 | -0.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.